1. Home /
  2. Life Sciences

Life Sciences

The Johnson & Johnson Charts Are Healthy Enough for Further Gains

Here's where traders could probe the long side of JNJ.

PerkinElmer Should Continue Its Rally to Record Highs in the Months Ahead

Traders should approach PKI from the long side at current levels.

AstraZeneca Is Moving the Needle

This drugmaker is making a historic upside breakout. Let's check the charts.

Surgical Device Maker Stryker Is Waiting to Move Higher

Let's review the charts and indicators.

Let's Shine a Light on Illumina's Breakout

Here's why ILMN could be bought on a shallow dip.

Exact Sciences Technical Correction Is Now Behind Us

Aggressive traders could go long EXAS at current levels.

Charts Warm Up to Thermo Fisher Scientific

The name is on Jim Cramer's buy-the-dip list, so let's check it out and see where traders could buy strength.

2 Promising Stocks to Watch on Eve of Annual Oncology Conclave

BeyondSpring Inc. and TG Therapeutics will be presenting at the American Society of Clinical Oncology's annual meeting.

Is It Too Late to Buy Progyny?

A Real Money subscriber asks. We answer.

Beam Therapeutics Is Ready to Beam Higher

Let's review the charts and indicators.